Cancer drugs. A pratical approach to drugs available to us

Par : Jean Trédaniel

Formats :

35,00 €
  • Paiement en ligne :
    • Livraison à domicile ou en point Mondial Relay indisponible
    • Retrait Click and Collect en magasin gratuit
  • Réservation en ligne avec paiement en magasin :
    • Indisponible pour réserver et payer en magasin
  • PrésentationBroché
  • Poids0.578 kg
  • Dimensions16,0 cm × 24,0 cm × 1,9 cm
  • ISBN978-2-7472-2044-6
  • EAN9782747220446
  • Date de parution03/03/2014
  • ÉditeurEska (Editions)
  • PréfacierMichel Marty

Résumé

What do doxorubicin and adriamycin have in common? Why can the indications for platinum compounds vary so much? Have monoclonal antibodies ousted cytotoxic drugs? What is an anticancer antibiotic? The aim of this book is to answer these questions, and all those that arise from being in contact with cancer drugs. To do this, we first need to classify each one in relation to the others. Each product is then described, detailing its official indications, as validated by its marketing license, then its dose, its mode of administration and the precautions that need to be taken when using it, any eventual resistance it may generate, and finally, the side effects it may cause.
What do doxorubicin and adriamycin have in common? Why can the indications for platinum compounds vary so much? Have monoclonal antibodies ousted cytotoxic drugs? What is an anticancer antibiotic? The aim of this book is to answer these questions, and all those that arise from being in contact with cancer drugs. To do this, we first need to classify each one in relation to the others. Each product is then described, detailing its official indications, as validated by its marketing license, then its dose, its mode of administration and the precautions that need to be taken when using it, any eventual resistance it may generate, and finally, the side effects it may cause.

A propos de Jean Trédaniel

Découvrir l'auteur